Total Payments
$3,936
2024 Payments
$647.59
Companies
44
Transactions
248
Medicare Patients
8,470
Medicare Billing
$329,572
Payment Breakdown by Category
Food & Beverage$3,885 (98.7%)
Other$44.55 (1.1%)
Education$6.00 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,885 | 246 | 98.7% |
| Debt forgiveness | $44.55 | 1 | 1.1% |
| Education | $6.00 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $459.91 | 29 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $396.99 | 19 | $0 (2022) |
| ABBVIE INC. | $320.27 | 18 | $0 (2024) |
| GlaxoSmithKline, LLC. | $302.71 | 26 | $0 (2024) |
| Merck Sharp & Dohme LLC | $198.65 | 11 | $0 (2023) |
| Novo Nordisk Inc | $159.54 | 11 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $146.63 | 20 | $0 (2018) |
| Antares Pharma, Inc. | $145.70 | 5 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $139.29 | 5 | $0 (2024) |
| PFIZER INC. | $131.85 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $647.59 | 32 | ABBVIE INC. ($161.31) |
| 2023 | $549.98 | 32 | Lilly USA, LLC ($177.74) |
| 2022 | $581.30 | 35 | Antares Pharma, Inc. ($107.44) |
| 2021 | $369.17 | 23 | AbbVie Inc. ($77.28) |
| 2020 | $123.28 | 9 | AstraZeneca Pharmaceuticals LP ($38.60) |
| 2019 | $431.19 | 24 | AstraZeneca Pharmaceuticals LP ($123.33) |
| 2018 | $430.24 | 25 | AstraZeneca Pharmaceuticals LP ($123.24) |
| 2017 | $802.82 | 68 | Merck Sharp & Dohme Corporation ($144.08) |
All Payment Transactions
248 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.30 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $33.15 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/30/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/22/2024 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Genetic Disease | ||||||
| 10/21/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $32.55 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $26.33 | General |
| Category: SCHIZOPHRENIA | ||||||
| 09/16/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: Diabetes | ||||||
| 09/06/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $18.58 | General |
| 08/21/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Diabetes | ||||||
| 08/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Diabetes | ||||||
| 08/01/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: PAIN | ||||||
| 07/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Cardio-renal | ||||||
| 06/28/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $33.95 | General |
| Category: NEUROSCIENCE | ||||||
| 06/26/2024 | VIVUS LLC | PANCREAZE (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/19/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $33.44 | General |
| Category: Psychology/Psychiatric | ||||||
| 06/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Cardio-renal | ||||||
| 05/24/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 05/23/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: NEUROSCIENCE | ||||||
| 05/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Diabetes | ||||||
| 05/08/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $30.98 | General |
| Category: Psychology/Psychiatric | ||||||
| 04/25/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.46 | General |
| 04/17/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 2,207 | 3,158 | $194,672 | $84,439 |
| 2022 | 27 | 1,993 | 2,815 | $177,440 | $79,073 |
| 2021 | 29 | 2,092 | 2,899 | $186,579 | $81,340 |
| 2020 | 31 | 2,178 | 3,015 | $207,149 | $84,720 |
Total Patients
8,470
Total Services
11,887
Medicare Billing
$329,572
Procedure Codes
116
All Medicare Procedures & Services
116 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 267 | 428 | $46,224 | $22,298 | 48.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 101 | 101 | $15,150 | $11,467 | 75.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 106 | 125 | $19,875 | $8,789 | 44.2% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 113 | 113 | $11,300 | $8,721 | 77.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 16 | 128 | $8,960 | $5,328 | 59.5% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2023 | 39 | 40 | $5,120 | $3,661 | 71.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 209 | 401 | $6,015 | $3,368 | 56.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 178 | 287 | $11,480 | $2,939 | 25.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 138 | 193 | $14,282 | $2,494 | 17.5% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 46 | 49 | $3,675 | $2,464 | 67.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 103 | 133 | $10,906 | $2,189 | 20.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 168 | 243 | $6,561 | $1,826 | 27.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 76 | 143 | $6,864 | $1,305 | 19.0% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 99 | 124 | $4,340 | $1,087 | 25.1% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 55 | 55 | $1,375 | $933.90 | 67.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 55 | 55 | $1,650 | $933.90 | 56.6% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 45 | 68 | $2,380 | $816.25 | 34.3% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 134 | 188 | $4,324 | $575.35 | 13.3% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 15 | 15 | $3,000 | $516.90 | 17.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 13 | 13 | $832.00 | $502.03 | 60.3% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 26 | 26 | $2,080 | $491.92 | 23.7% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 43 | 56 | $1,960 | $447.66 | 22.8% |
| 80076 | Liver function blood test panel | Office | 2023 | 35 | 43 | $1,419 | $336.42 | 23.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 34 | 35 | $1,750 | $235.84 | 13.5% |
| 83721 | Ldl cholesterol level | Office | 2023 | 20 | 21 | $1,092 | $205.80 | 18.8% |
About Dr. John Reesor, M.D
Dr. John Reesor, M.D is a Family Medicine healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1447255922.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Reesor, M.D has received a total of $3,936 in payments from pharmaceutical and medical device companies, with $647.59 received in 2024. These payments were reported across 248 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($3,885).
As a Medicare-enrolled provider, Reesor has provided services to 8,470 Medicare beneficiaries, totaling 11,887 services with total Medicare billing of $329,572. Data is available for 4 years (2020–2023), covering 116 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Lexington, KY
- Active Since 06/20/2005
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1447255922
Products in Payments
- FARXIGA (Drug) $354.33
- MOUNJARO (Drug) $318.98
- VRAYLAR (Drug) $139.18
- TRELEGY ELLIPTA (Drug) $117.48
- BELSOMRA (Drug) $113.20
- QULIPTA (Drug) $108.80
- NOCDURNA (Drug) $107.44
- XIFAXAN (Drug) $91.46
- Auvelity (Drug) $87.88
- NURTEC ODT (Drug) $81.13
- Vascepa (Drug) $78.33
- BREO (Drug) $76.17
- Aimovig (Biological) $75.69
- JARDIANCE (Drug) $71.38
- TRINTELLIX (Drug) $71.12
- XARELTO (Drug) $66.45
- TRULICITY (Drug) $64.23
- FANAPT (Drug) $59.48
- ABILIFY MAINTENA (Drug) $57.08
- Ozempic (Drug) $56.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Lexington
Dr. Keith Stokes, Md, MD
Family Medicine — Payments: $550,575
Family Medicine $550,575
John Richard, Md, MD
Family Medicine — Payments: $438,915
Family Medicine $438,915
Dr. Susan Neil, Md, MD
Family Medicine — Payments: $23,499
Family Medicine $23,499
William Crigler, Md, MD
Family Medicine — Payments: $18,109
Family Medicine $18,109
Dr. Mark Weiser, Md, MD
Family Medicine — Payments: $12,183
Family Medicine $12,183
Dr. William Dacus, Md, MD
Family Medicine — Payments: $11,475
Family Medicine $11,475